Literature DB >> 6125825

Psoriasis and leukotriene B4.

S D Brain, R D Camp, P M Dowd, A K Black, P M Woollard, A I Mallet, M W Greaves.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6125825     DOI： 10.1016/s0140-6736(82)90939-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  Studies of polymorphonuclear migration into psoriatic skin using a new in vivo method.

Authors:  B Guillot; M Coupe; M Alirezai; J P Bureau; J J Guilhou
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

2.  Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.

Authors:  P M Dowd; A K Black; P W Woollard; M W Greaves
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Arachidonic acid and LTB4 enhance aggregation of psoriatic peripheral blood mononuclear leukocytes in vitro.

Authors:  P D Pigatto; M M Polenghi; G F Altomare; G L Tadini; S Villa
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

4.  Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

5.  Dermatology: leukotrienes-their importance in dermatology.

Authors:  M E Goldyne
Journal:  West J Med       Date:  1985-08

6.  Chemotactic lipoxygenase products in sera from patients with psoriasis.

Authors:  K Fogh; T Ternowitz; K Kragballe; T Herlin
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

7.  FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.

Authors:  A Blackham; R J Griffiths; C Hallam; J Mann; P D Mitchell; A A Norris; W T Simpson
Journal:  Agents Actions       Date:  1990-06

Review 8.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

Review 9.  Leukotriene B4 and platelet-activating factor in human skin.

Authors:  L Michel; L Dubertret
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

10.  A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile.

Authors:  F Grimminger; P Mayser; C Papavassilis; M Thomas; E Schlotzer; K U Heuer; D Führer; K D Hinsch; D Walmrath; W B Schill
Journal:  Clin Investig       Date:  1993-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.